Skip to contentPOTTER MYRTLE S — GENENTECH INC insider: 639 transactions · InsiderLensPOTTER MYRTLE S
- Director at FOXHOLLOW TECHNOLOGIES, INC. · on record since Jan 10, 2006
- Director at GENENTECH INC · on record since Jun 14, 2024
- Director at AMAZON COM INC · on record since Apr 16, 2007
- Director at MEDCO HEALTH SOLUTIONS INC · on record since Nov 30, 2007
- Director at ev3 Inc. · on record since Oct 9, 2007
- Director at EXPRESS SCRIPTS INC · on record since May 22, 2012
- Director at RITE AID CORP · on record since Dec 3, 2013
- Director at Everyday Health, Inc. · on record since Mar 27, 2014
- Director at INSMED INC · on record since Dec 15, 2014
- PRESIDENT, at GENENTECH INC · on record since Sep 27, 2004
- Director at Axsome Therapeutics, Inc. · on record since Jun 19, 2017
- Director at Urovant Sciences Ltd. · on record since Sep 26, 2018
- Director at Myovant Sciences Ltd. · on record since Sep 24, 2018
- Director at Arbutus Biopharma Corp · on record since Oct 22, 2018
- Director at TASER INTERNATIONAL INC · on record since Oct 16, 2018
- Director at Immunovant, Inc. · on record since Dec 20, 2019
- Director at Guardant Health, Inc. · on record since Oct 27, 2021
Insider trading activity of POTTER MYRTLE S
- Transactions on record
- 639
- since Sep 8, 2003
- Open-market buys
- 1
- Open-market sells
- 151
- $2.3M
- Companies traded
- 16
- last filing Jun 23, 2026
Figures computed from official regulatory filings — methodology.
Companies where POTTER MYRTLE S has traded
- Guardant Health, Inc.100 tx · $137.8K · Jun 23, 2026
- GENENTECH INC413 tx · Jun 13, 2025
- Myovant Sciences Ltd.10 tx · Mar 10, 2023
- Urovant Sciences Ltd.10 tx · Mar 31, 2021
- Immunovant, Inc.4 tx · Dec 20, 2019
- Arbutus Biopharma Corp2 tx · Aug 20, 2019
- Axsome Therapeutics, Inc.5 tx · Jun 10, 2019
- TASER INTERNATIONAL INC2 tx · Apr 17, 2019
- INSMED INC9 tx · $82.7K · May 17, 2018
- RITE AID CORP
Track record of POTTER MYRTLE S
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of POTTER MYRTLE S
Co-insiders of POTTER MYRTLE S
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · $58.9K · Oct 5, 2017
Viking Global Opportunities Illiquid Investments Sub-Master LPArbutus Biopharma Corp +4
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 23, 2026 | Sell | -1,556 | 131.16 USD | — | SEC |
| Jun 22, 2026 | AwardD | 2,711 | 0.00 USD | — | SEC |
| Jun 22, 2026 | Exercise | 4,203 | 0.00 USD | — | SEC |
| Jun 22, 2026 | ExerciseD | -4,203 | 0.00 USD | — | SEC |
| Oct 20, 2025 | Sell | -26 | 66.95 USD | $1.7K | SEC |
| Oct 16, 2025 | Exercise | 69 | 0.00 USD | $0 | SEC |
| Oct 16, 2025 | ExerciseD | -69 | 0.00 USD | $0 | SEC |
| Sep 17, 2025 | ExerciseD | -68 | 0.00 USD | $0 | SEC |
| Sep 17, 2025 | Exercise | 68 | 0.00 USD | $0 | SEC |
| Sep 17, 2025 | Sell | -26 | 55.63 USD | $1.4K | SEC |
| Aug 20, 2025 | Sell | -26 | 59.02 USD | $1.5K | SEC |
| Aug 18, 2025 | ExerciseD | -69 | 0.00 USD | $0 | SEC |
| Aug 18, 2025 | Exercise | 69 | 0.00 USD | $0 | SEC |
| Jul 18, 2025 | Sell | -26 | 48.20 USD | $1.3K | SEC |
| Jul 16, 2025 | Exercise | 68 | 0.00 USD | $0 | SEC |
| Jul 16, 2025 | ExerciseD | -68 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | AwardD | 6,833 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | AwardD | 4,203 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | Sell | -26 | 49.47 USD | $1.3K | SEC |
| Jun 16, 2025 | Sell | -2,626 | 49.70 USD | $130.5K | SEC |
| Jun 16, 2025 | ExerciseD | -69 | 0.00 USD | $0 | SEC |
| Jun 16, 2025 | Exercise | 69 | 0.00 USD | $0 | SEC |
| Jun 16, 2025 | ExerciseD | -6,674 | 0.00 USD | $0 | SEC |
| Jun 16, 2025 | Exercise | 6,674 | 0.00 USD | $0 | SEC |
| Jun 13, 2025 | ExerciseD | -10,822 | — | — | SEC |